Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses-Reference-Cited by-同舟云学术

Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses

Published:2023-10 Issue: Volume:57 Page:475-486
ISSN:2405-4577
Container-title:Clinical Nutrition ESPEN
language:en
Short-container-title:Clinical Nutrition ESPEN

Author:

Mahapatro Abinash^ORCID,Bawna Fnu,Kumar Vikash,Daryagasht Amir Ali,Gupta Siddharth,Raghuma Nakka^ORCID,Moghdam Saman Soltani,Kolla Akshita,Mahapatra Shruti Sagar^ORCID,Sattari Nazila^ORCID,Amini-Salehi Ehsan,Nayak Sandeep S.

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference111 articles.

1. Non-alcoholic fatty liver disease;Smith;Crit Rev Clin Lab Sci,2011

2. NASH: a global health problem;Sanyal;Hepatol Res,2011

3. Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts;Papatheodoridi;Curr Pharm Des,2018

4. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease;Souza;Arq Gastroenterol,2012

5. Risk factors associated with non-alcoholic fatty liver disease in Indians: a case-control study;Singh;J Clin Exp Hepatol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of Lactobacillus plantarum PS128 in patients with major depressive disorder: an eight-week double-blind, placebo-controlled study;Asian Journal of Psychiatry;2024-11

2. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries;Archives of Medical Research;2024-09

3. Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review;Nutrition, Metabolism and Cardiovascular Diseases;2024-09

4. Gut microbiota interventions in type 2 diabetes mellitus: An umbrella review of glycemic indices;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-08

5. Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact;Hepatology International;2024-07-12